secwatch.observer — SEC 8-K summary
======================================

Issuer:     MiNK Therapeutics, Inc. (INKT)
CIK:        0001840229
Form:       8-K
Filed at:   2026-01-02T23:59:59+00:00
Accession:  0001193125-26-000916
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Robert Kadlec resigns from MiNK Therapeutics board for U.S. government role
--------------------------------------------------------------------------------

- Robert Kadlec, MD, resigned from the Board of Directors effective December 29, 2025.
- Resignation due to acceptance of senior public service role as Assistant Secretary of War for Nuclear Deterrence and Chemical and Biological Defense Policy and Programs.
- Dr. Kadlec joined the Board in October 2024; no replacement announced.
- Company expressed appreciation for his service and perspective.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840229/000119312526000916/0001193125-26-000916-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840229/000119312526000916/inkt-20251229.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-000916

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer